Evidence · Eligibility · Physician oversight
A thoughtful conversation about peptide therapy.
Private peptide therapy consultations in Beverly Hills, with attention to the exact treatment, the reason for considering it and the care required around it.
- Board-certified physician
- Private Beverly Hills practice
- LGBTQ+ affirming
Start with the clinical question
The specific medication matters.
Peptides are a broad class of molecules. The term alone does not tell you what a treatment does, whether it is approved for a particular condition or whether its benefits outweigh its risks. A useful consultation begins with your health concern and the evidence for a specific medication.
At his Beverly Hills practice, Dr. Ingulsrud provides a physician-led setting to discuss peptide treatment, review eligibility and consider alternatives. Bring the name of any product you are taking or considering, along with your medication list and relevant records. A consultation may lead to further evaluation, a treatment discussion, a referral or a recommendation to take a different approach.
Individualized care
Clarity before a prescription.
Availability and suitability are confirmed individually. Each treatment requires its own assessment; there is no universal peptide protocol.
Your reason for treatment
Clarify the symptoms, diagnosis or measurable clinical goal behind the request and what has already been evaluated.
Evidence & indication
Review what is known about the exact medication, its intended use and where the evidence remains limited.
Individual eligibility
Discuss medical history, prior cancer, endocrine conditions, pregnancy considerations, allergies and other relevant factors.
Medication review
Bring prescription medicines, supplements and current injections so interactions and overlapping therapies can be considered.
Baseline & follow-up
Identify which examinations or laboratory tests are needed before treatment and what would be monitored afterward.
Alternatives & reassessment
Consider established options and define when to continue, change or stop a plan based on benefit and tolerability.
A considered approach
A precise indication deserves a precise explanation.
For example, FDA-approved tesamorelin is indicated for excess abdominal fat in adults with HIV-associated lipodystrophy. It is not indicated for general weight-loss management, and its long-term cardiovascular safety has not been established. An approved use of one medication does not validate broad anti-aging claims for peptides as a group.
What to expect
A clear process, from first conversation through follow-through.
- 01
Bring the details.
Share the exact product name, your goals, relevant diagnoses and any previous treatment experience.
- 02
Evaluate the fit.
Review the evidence, medical context, potential risks and whether another explanation needs attention first.
- 03
Make an informed decision.
Discuss reasonable expectations, alternatives, practical requirements and costs before proceeding.
- 04
Monitor deliberately.
If treatment is appropriate, agree on follow-up, required testing and the findings that would prompt reassessment.
Who this may serve
For patients who want an informed medical decision.
- Patients seeking a clinical review of a specific peptide treatment
- People who want to understand evidence and approved indications
- Patients bringing questions about an existing prescription
- People coordinating treatment with HIV or other specialty care
- Patients who value ongoing physician monitoring
Common questions
Peptide Therapy Consultations, explained clearly.
Does every peptide have the same benefits or risks?
No. Peptides differ in their actions, evidence, approval status and risks. Treatment decisions must be specific to the medication and the patient rather than based on the word peptide.
Is tesamorelin a general weight-loss medication?
No. Its FDA-approved indication is reduction of excess abdominal fat in adults with HIV-associated lipodystrophy. General weight management is a separate clinical discussion.
Does a consultation guarantee a prescription?
No. Dr. Ingulsrud first considers the clinical question, evidence, risks and alternatives. Further testing, specialist input or a different approach may be more appropriate.
Are compounded peptides FDA-approved?
Compounded drugs are not FDA-approved. FDA does not review them for safety, effectiveness or quality before marketing. A compounded product should not be described as equivalent to an approved medicine simply because it names a similar ingredient.
What monitoring might be needed?
It depends on the medicine. For tesamorelin, the prescribing information includes assessment of glucose and IGF-1, along with attention to cancer history, fluid retention and other risks. Your physician determines the monitoring appropriate to your situation.
Can I discuss a product I bought online?
Yes. Bring its label and source information to the consultation. A label or research-use claim does not establish suitability for human treatment. Do not start or combine injections based on online marketing alone.
Clinical references
Credible guidance for informed decisions.
Sources are provided for general education. Screening, diagnosis, medication and treatment decisions should be made with a qualified clinician based on individual circumstances and current guidance.
Begin the conversation
Private care with more time, context and continuity.
Request an appointment and the practice team will confirm availability and explain the next step. Please do not include sensitive medical information in the online form.
This page is for general informational purposes and does not create a physician–patient relationship or replace individualized medical advice. If you are experiencing a medical emergency, call 911 or go to the nearest emergency department.